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Platelet-derived growth factor (PDGF) is a
potent mitogen produced by multiple vascular cells,
including platelets, leukocytes, macrophages, endo-
thelial cells (ECs), and smooth muscle cells (SMCs)
in normal and pathologic conditions.1 PDGF is
mitogenic for most mesenchymal cells, including
SMCs, for which it is also chemotactic in vitro.2,3
Thus, PDGF may be important in mediating vessel
wall responses to injury through paracrine stimula-
tion.4 PDGF is found in regions of inflammation
and in proliferative lesions.3 Increased PDGF
mRNA expression and PDGF production by SMCs
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Objective: Platelet-derived growth factor (PDGF) is a potent smooth muscle cell mitogen
implicated in the development of intimal hyperplasia and atherosclerosis. A regional
variation in canine aortic production of PDGF (greater in the distal than in the proxi-
mal aorta) was demonstrated previously in organ culture. The response of aortic seg-
ments in organ culture, as well as of aortic endothelial cells and smooth muscle cells, to
stimulators of PDGF secretion—phorbol 12-myristate 13-acetate (PMA) and throm-
bin—was assessed to elucidate whether these regional variations were due to intrinsic
differences in the abilities of cells to produce PDGF.
Methods: Proximal and distal aortic segments were removed from 10 dogs and placed in
organ culture, then treated with PMA or thrombin for 72 hours. PDGF in the condi-
tioned media was measured by radioreceptor assay.
Results: PDGF production in the distal, unstimulated aorta was 2.5-fold higher than
that in the proximal aorta (P < .05). Treatment of the proximal aorta with 10 nmol/L
and 100 nmol/L PMA increased PDGF production twofold and threefold, respectively,
whereas no increase with PMA treatment was seen in the distal aorta. After thrombin
treatment, no increase in PDGF production was noted in the proximal aorta and only a
minimal increase was noted in the distal aorta. Endothelial cells and smooth muscle cells
(n = 6) were cultured from four aortic segments (ascending thoracic, descending tho-
racic, abdominal, and infrarenal) and treated with PMA. PDGF production by unstim-
ulated endothelial cells from the infrarenal aorta was 2.5-fold higher (P < .01) than that
from the ascending thoracic aorta. With PMA treatment, PDGF secretion increased in
endothelial cells from all segments, the greatest percentage increase being observed in
the proximal segments. Thrombin also increased PDGF release from endothelial cells,
but with no regional variation. Unstimulated smooth muscle cells did not exhibit
regional variation in PDGF production and did not increase PDGF secretion after treat-
ment with PMA or thrombin.
Conclusions: These findings suggest that endothelial cells in the aorta may have a differ-
ential capacity to produce PDGF in response to stimulants, reflecting intrinsic differ-
ences in endothelial cells from the proximal aorta versus the distal aorta, and this may
account in part for the propensity of the distal aorta to develop atherosclerosis. (J Vasc
Surg 2000;32:584-92.)
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from human atherosclerotic lesions has been report-
ed,5,6 suggesting that PDGF may be important in
atherosclerotic plaque formation and progression.
A previous study demonstrated regional variation
in PDGF production in the canine aorta,7 which is
of interest given the possible role of PDGF in ath-
erosclerosis. In that study, segments of the distal
aorta produced significantly more PDGF in organ
culture than did the proximal aorta.
The current study addressed the capacity of various
regions of the aorta to respond to phorbol 12-
myristate 13-acetate (PMA), a known stimulator of
PDGF production,8,9 and to thrombin, a serine pro-
tease previously shown to upregulate PDGF mRNA
expression and release of PDGF.8-11 The purpose of
this study was to determine whether the higher PDGF
production by the distal aorta was due to a generalized
“activation” or to a unique property distal aortic cells.
The studies suggest that the regional variation in stim-
ulated PDGF production by aortic segments in organ
culture is unique and not duplicated by cellular
responses in tissue culture. If there are intrinsic differ-
ences in the cells within the aorta, perhaps based on a
difference in embryogenesis, these differences may be
obscured by the harvesting and culture of the cells.
Thus, results from organ culture may provide impor-
tant clues regarding cell function in vivo and regional
differences that contribute to the propensity of the dis-
tal aorta to develop atherosclerosis.
METHODS
Materials. Trypsin, medium 199 (M199),
Dulbecco modified Eagle medium nutrient mixture
F12-Ham (DME/F12), gentamicin, sodium bicar-
bonate, Triton X-100, 2.5% glutaraldehyde, calf thy-
mus DNA (type I, sodium salt), thrombin, con-
trolled processed serum replacement, bisbenzimide,
and antibody to smooth muscle–specific alpha-actin
were purchased from Sigma Chemical (St Louis,
Mo). Collagenase A, human recombinant PDGF-
AB, bovine serum albumin, and elastase type II were
purchased from Boehringer Mannheim (India-
napolis, Ind). Fetal bovine serum (FBS) was
obtained from HyClone Laboratories (Logan,
Utah). [3H]-Leucine was purchased from DuPont
Diagnostic Imaging Division (Boston, Mass).
Fibronectin was obtained from Collaborative
Research, Inc (Bedford, Mass). Heparin sodium was
obtained from Elkins-Sinn, Inc (Cherry Hill, 
NJ). EC growth supplement was isolated from
bovine hypothalami purchased from Rockland
(Gilbertsville, Pa). Sylgard 184 silicone elastomer
was obtained from Dow Corning Corporation
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(Midland, Mich). Monoclonal antibodies against
factor VIII were obtained from Chemicon
International (Temecula, Calif).
Aortic harvest. For the study of PDGF produc-
tion, aortas were harvested from adult mongrel dogs
killed for other studies not involving pharmacologic
or surgical manipulation of the aorta. The animal
care guidelines established in the “Principles of
Laboratory Animal Care” and “Guide for the Care
and Use of Laboratory Animals” (NIH Publication
No. 80-23, revised 1985) were followed. With the
animals anesthetized and intubated, the dogs were
given heparin 150 U/kg and papaverine 90 ng/kg.
A longitudinal thoracoabdominal incision was made
and the aorta exposed from the aortic valve to the tri-
furcation. The root of the aorta was cross-clamped,
and the aorta was immediately flushed with 1 L of
M199 containing 2.2 mg/mL of sodium bicarbon-
ate as the animal was killed. Periadventitial tissue was
carefully dissected from the aorta, and the aorta was
removed for organ culture studies or cell harvest.
Organ culture. Each aorta was divided into a
proximal segment, extending from the aortic arch to
the first intercostal, and a distal segment, extending
from the renal arteries to the trifurcation. Each seg-
ment was cut into two longitudinal pieces and
pinned on Sylgard elastomer discs for organ cul-
ture.7,12 One piece was assigned to the control
group (n = 10); the other piece was assigned to
either the PMA 10 nmol/L group (n = 5) or the
PMA 100 nmol/L group (n = 5). The pieces were
washed with M199, placed in 6-well tissue culture
dishes in 4 mL of M199 containing 15 U/mL of
heparin sodium, 0.15 mg/mL of EC growth sup-
plement, 0.05 mg/mL of gentamicin, 2.2 mg/mL
of sodium bicarbonate, 10% controlled processed
serum replacement-2 (a serum substitute with low
mitogenic activity), and 2% FBS at 37°C with 5%
CO2. One hour later, the medium was removed and
replaced either with an equal volume of the same
medium containing 0, 10, or 100 nmol/L PMA or
with thrombin 20 U/mL for 72 hours.
Cell culture. For cell culture, the aorta was har-
vested and divided into four segments, as follows:
(1) ascending thoracic aorta and aortic arch, from
the aortic root to the first intercostal artery; (2)
descending thoracic aorta, from the first intercostal
artery to the celiac axis; (3) abdominal aorta, from
the celiac axis to the renal arteries; (4) infrarenal
aorta, from the renal arteries to the trifurcation. The
first of these segments corresponded to the proximal
segment in organ culture; the fourth segment corre-
sponded to the distal segment in organ culture.
The aortic segments were incubated in collage-
nase A (630 U/mL) for 10 minutes at 37°C in a 5%
CO2 atmosphere to harvest ECs. ECs were removed
by gentle scraping with a rounded spatula, placed in
6-well plates coated with fibronectin, and grown to
confluence in M199 with 20% FBS. The cells were
harvested with a 0.05% trypsin solution for 5 min-
utes at 37°C. ECs were seeded in 12-well plates
coated with fibronectin at a density of 1.0 × 105 per
well. At confluence, the medium was changed to
M199 with 5% FBS. PDGF production was mea-
sured in first-passage ECs. EC purity was confirmed
through use of monoclonal antibodies against factor
VIII–related antigen.
SMCs were harvested from segments after removal
of all ECs by a second, more vigorous scraping. The
medial layer was then stripped from the aorta and
placed in 15-mL conical tubes with 5 mL of M199
containing 2 mg/mL crystalline bovine serum albu-
min, 0.375 mg/mL soybean trypsin inhibitor, 15
U/mL elastase type II, and 170 U/mL collagenase A;
it was then agitated for 2 hours. The medium was cen-
trifuged at 300g for 5 minutes. The resulting pellet
was resuspended in M199 with 20% FBS and placed in
a 6-well culture plate, and the SMCs were grown to
confluence. SMC purity was confirmed through use of
antibody to smooth muscle–specific alpha-actin. The
cells were harvested with a 0.05% trypsin solution for
5 minutes at 37°C and seeded in 12-well plates at a
density of 1.0 × 105 per well. At confluence, the medi-
um was changed to M199 with 5% FBS. All experi-
ments were done with first-passage SMCs.
PDGF assay. PDGF was measured through use
of a radioreceptor assay, described by Fox and
DiCorleto,13 that measures competition with 125I-
labeled PDGF for binding to receptors on human
foreskin fibroblasts. The assay has a sensitivity of 10
to 20 pg and is able to detect all PDGF dimer iso-
forms (AA, AB, and BB). PDGF-AB was labeled
through use of the method of Heldin et al.14
Medium conditioned by organ cultures was concen-
trated sevenfold with a Centriprep-10 concentrator
(Amicon, Beverly, Mass) before PDGF assay; medi-
um conditioned by cell cultures was not concentrat-
ed. Sparse, quiescent human foreskin fibroblasts
were incubated with 50 to 200 mL of conditioned
medium and N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid–buffered DME/F12 containing
2 mg/mL bovine serum albumin for 1 hour. The
cells were washed, and 125I-PDGF was added for 1
additional hour.13 Cell-bound radioactivity was
measured by a γ radiation counter. Through use of
known amounts of PDGF, a standard curve was gen-
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erated by nonlinear regression with the logistic
equation. PDGF production was expressed as
pg/cm2 of tissue for organ culture and as pg/µg of
DNA for tissue culture.
DNA assay. DNA was quantitated in cultured
cells according to the method of Labarca and
Paigen.15 Cells were harvested through use of 0.05%
trypsin and sonicated briefly with a microtip sonica-
tor. Twenty-five microliters of the sonicated mixture
was diluted to a volume of 750 µL with phosphate-
buffered saline solution containing 4 mol/L NaCl
and 0.2 µg/mL bisbenzimide. The absorbance was
measured by means of a spectrofluorophotometer
(model RF-1501, Shimadzu, Giangarlo Scientific
Co, Inc, Pittsburgh, Pa). A primary filter of 356 nm
and a secondary filter of 458 nm were used. A stan-
dard emission curve was prepared with known
amounts of calf thymus DNA. Results were deter-
mined through use of nonlinear regression and
expressed as µg of DNA per well.
Protein synthesis. Secreted protein synthesis
and cell-associated protein synthesis were deter-
mined after incubation of cells with [3H]-leucine
for 24 hours. Trichloroacetic acid (TCA)–precip-
itable material was measured according to the
method of Fox and DiCorleto.13 The conditioned
medium was collected and protein was precipitated
through use of chilled 5% TCA and 0.25% tannic
acid to measure secreted protein synthesis. Cell-
associated protein synthesis was determined by
lysing the remaining cells and precipitating protein
with chilled 5% TCA. In both cases, the precipitate
was solubilized with 0.25 N NaOH, then neutral-
ized with 50 µL 6 N HCl. Radioactivity was deter-
mined in a scintillation counter and expressed as
percent of applied [3H]-leucine incorporated into
TCA-precipitable material.
Scanning electron microscopy. Organ culture
specimens were prepared for scanning electron
microscopy by dehydration in graded ethanols and
hexamethyldisilazine, then coated with gold in an
RMC-EIKO IB-3 ion coater (Research Manu-
facturing Co, Inc, Tucson, Ariz). Scanning electron
microscopy was performed by an investigator blinded
to the segment locations or the treatments. A Jeol
JSM-840-A electron microscope (Jeol USA, Inc,
Peabody, Mass) was used. Endothelial coverage was
determined at 10 grid intersections on 10 random
fields per segment at a magnification of ×1000. Cell
surface activity, separation of cellular junctions, cellular
craters, adhering noncellular material, and detachment
or absence of ECs were indicators of cellular injury. An
injury scale from 0 to 4 was devised, as follows:
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0: no injury
1: craters (1 to 2) in less than 10% of cells; slight
separation of cellular junctions; a small amount
of noncellular adherent material
2: an increased number of craters (3-5) per cell and
an increased number of cells with craters; EC
contraction and greater cell surface activity
3: craters in all cells or more than five craters per
cell; large numbers of cells lifting off or with ten-
uous attachments
4: complete endothelial denudation, with platelets
and leukocytes covering the substratum
Statistical analysis. Results were expressed as
means ± SEMs when appropriate. Analysis of vari-
ance was performed to compare PDGF production
among aortic segments and PMA treatment groups.
RESULTS
PDGF production by organ culture. Previous
studies in our laboratory showed that PDGF pro-
duction by the proximal canine aorta is significantly
less than PDGF production by the distal aorta.
PDGF production by unstimulated and stimulated
aortic segments was measured to investigate whether
this difference is due to intrinsic differences in capac-
ity to produce PDGF. PDGF production by unstim-
ulated segments was nearly threefold higher in distal
than in proximal aortic segments (Fig 1, A).
Stimulation with PMA 10 nmol/L (n = 5) and 100
nmol/L (n = 5) resulted in a dose-dependent
increase in PDGF production in the proximal aorta
but not in the distal aorta. EC injury in organ cul-
ture segments, as assessed by scanning electron
microscopy, increased in a parallel, dose-dependent
manner with PMA treatment in both proximal and
distal segments (Fig 1, B). Proximal and distal con-
trol segments were characterized by one to two
craters in a few cells, with small amounts of noncel-
lular adherent material. All segments in the 10-
nmol/L PMA treatment group were characterized
by moderate crater formation (2-3 craters per cell),
EC detachment, and greater cell surface activity. In
the 100 nmol/L PMA treatment group, both prox-
imal and distal segments were characterized by
extensive crater formation in cells (3-5 craters per
cell) as well as cellular detachment (Fig 1, B).
Proximal and distal aortic segments were stimu-
lated with thrombin 20 U/mL to more fully charac-
terize these regional differences (Fig 2). The proxi-
mal unstimulated segments produced 20.6 ± 0.17
pg/cm2; after treatment with thrombin, they pro-
duced 15.31 ± 2 pg/cm2. Distal unstimulated seg-
ments produced 52.5 ± 6 pg/cm2; after stimulation
with thrombin, they produced 61.9 ± 5.7 pg/cm2.
These experiments were repeated four times.
PDGF production by cultured cells. ECs (Fig 3)
and SMCs (Fig 4) cultured from the proximal and the
distal canine aorta were treated with PMA for 72 hours
to investigate which cells are responsible for the differ-
ences in PDGF production after PMA treatment of
organ cultures. PDGF production by untreated ECs
from the proximal aorta (ascending and descending
thoracic) was significantly lower (P < .05) than pro-
duction by untreated ECs from the distal aorta
(abdominal and infrarenal). PMA treatment resulted
in a dose-dependent increase in PDGF production by
ECs from each aortic segment, with the percent
Fig 1. PMA stimulation of PDGF secretion by proximal and
distal canine aorta in organ culture. Aortic segments were
incubated with 0, 10, or 100 nmol/L PMA for 72 hours.
PDGF was measured by radioreceptor assay (A); injury
severity of the aortic segments was assessed by scanning elec-
tron microscopy (B) and graded on a scale of 0 to 4, 4 being
the most severely injured. These experiments were repeated
five times through use of aortic segments from five different
dogs. Results shown are means of five experiments.
A
B
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increase highest for ECS from the two proximal seg-
ments. Treatment of the ascending aortic ECs (seg-
ment 1) with 100 nmol/L PMA resulted in an
increase in PDGF production from 511 ± 203 to 7041
± 3569 pg/µg DNA (P < .05); PDGF production by
the abdominal aortic ECs (segment 4) increased from
1233 ± 306 to 10,556 ± 2257 pg/µg DNA (P < .05)
with 100 nmol/L PMA treatment. After PMA treat-
ment, distal ECs continued to produce higher
amounts of PDGF than proximal ECs; however, the
difference was not statistically significant.
PDGF production by ECs in vitro was stimulat-
ed with 20 U/mL thrombin to determine whether
canine aortic ECs were uniquely unresponsive to
thrombin. EC production of PDGF increased in a
range from fivefold to 14-fold in response to throm-
bin treatment (data not shown). Addition of heparin
to thrombin treatment resulted in a doubling of
PDGF secreted into the medium (data not shown).
PDGF production by unstimulated SMCs har-
vested from normal aorta was low, ranging from 53
± 25 to 72 ± 24 pg/µg DNA. There was no signifi-
cant difference in PDGF production among SMCs
harvested from different segments of the aorta, nor
did PMA have a statistically significant stimulatory
effect on SMCs cultured from any segment (Fig 4).
Similarly, thrombin treatment of SMCs did not
increase PDGF production by SMCs (data not
shown). The concentrations of PDGF measured
were, however, at the lower limits of this assay.
Total secreted protein synthesis by organ culture
was measured, and both cell-associated protein syn-
thesis and secreted protein synthesis by cultured ECs
and SMCs were measured to determine whether
changes in PDGF secretion were specific or were a
reflection of generalized cellular activation. No sta-
tistically significant differences were found in protein
synthesis in organ culture (Fig 5) after treatment
with PMA (Fig 5, A) or thrombin (Fig 5, B); simi-
larly, no differences were noted in EC (Tables I and
Fig 2. Thrombin stimulation of PDGF secretion by prox-
imal and distal canine aorta in organ culture. Proximal and
distal aortic segments from four different dogs were incu-
bated with 0 or 20 U/mL thrombin for 72 hours. PDGF
was measured by radioreceptor assay. Results shown are
means of four separate experiments.
Fig 3. PMA stimulation of PDGF secretion in cultured
canine aortic ECs. Conditioned medium was collected
from ECs (n = 6) incubated with 0, 10, or 100 nmol/L
PMA for 72 hours. PDGF was measured by radioreceptor
assay. Results shown are means of six experiments in which
EC cultured from six different dogs were used.
Fig 4. PMA stimulation of PDGF secretion in cultured
canine aortic SMCs. Conditioned medium was collected
from SMCs (n = 6) incubated with 0, 10, or 100 nmol/L
PMA for 72 hours. PDGF was measured by radioreceptor
assay. Results shown are means of six experiments in which
SMCs from six different dogs were used.
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II) and SMC protein synthesis in cell culture (results
not shown). These results suggested that changes in
PDGF production were specific and not part of a
generalized increase in cellular metabolism.
DISCUSSION
Aortic atherosclerosis is commonly more severe in
the infrarenal segment than other parts of the aorta.
Although the development of atherosclerosis is rare in
normal dogs, when dogs are fed an atherogenic diet
and treated with thiouracil, they develop atheroscle-
rotic lesions similar in morphology and distribution to
those seen in human atherosclerosis, with relative
sparing of the thoracic aorta and lesion formation in
the abdominal aorta that increases in severity toward
and beyond the bifurcation.16 Other animal models
also show similar patterns of atherosclerosis develop-
ment.17 Our previous studies show that PDGF 
production by the distal aorta is greater than PDGF
production by the proximal aorta in dogs, a regional
variation also noted in pigs and cows.7 The regional
difference in PDGF secretion may be due to intrinsic
differences in proximal and distal aortic cells or to
environmental influences. Given the possible role of
PDGF in proliferative lesions, identification of the
cause of this elevated mitogen production in the dis-
tal aorta might provide insight into the regional dif-
ferences in atherosclerosis.
The ability of both segments to increase PDGF
production in response to stimulators was studied to
determine whether proximal and distal aortic seg-
ments can produce equivalent amounts of PDGF.
Activators of protein kinase C (PKC), such as PMA,
are known to increase PDGF gene expression and
protein production.8,9,18,19 The lack of response of
the distal aortic segments to PMA is a novel finding
and not readily explained. PMA is known to cause cell
injury,13 and variable sensitivity to the injurious effect
of PMA could account for the segmental difference in
PDGF production seen in organ culture. Evidence of
cellular injury from scanning electron microscopy,
however, is similar in the proximal and distal aortic
segments. Therefore, differences in injury do not
account for differences in response to PMA.
The lack of response to PMA treatment in the dis-
tal aorta is not due to an inability of distal aortic ECs
to respond to the stimulus, inasmuch as cultured ECs
increased PDGF secretion after PMA treatment.
Similarly, other investigators report that PMA (10-
100 ng/mL) increases PDGF secretion and message
for both PDGF-A and PDGF-B chains in ECs in
vitro.8,9,20 This does not appear simply to be release
of stored PDGF, because higher concentrations of
PMA (≥1000 nmol/L), which are toxic to bovine
ECs, cause only minimal increases in PDGF secre-
tion.13 The lack of response of the distal aorta cannot
be assigned merely to depletion of PKC by prolonged
exposure to PMA, because the proximal aorta
responded under the same conditions. In addition,
our previous study showed no increase in monocytic
cell adhesion to distal aortic segments after a brief (6-
hour) exposure to PMA, a sharp contrast to the
twofold increase in adhesion to the proximal aorta
after PMA treatment.21 Interestingly, in the present
study, ECs cultured from the proximal aorta produce
less PDGF than do distal aortic ECs. Although PMA
treatment results in increased PDGF secretion from
both proximal and distal aortic ECs, PDGF secretion
by distal aortic ECs continues to be higher than
PDGF secretion by proximal aortic ECs at both con-
centrations of PMA, a fact that supports the idea of an
intrinsic difference in ECs from the two locations.
The contribution of aortic SMCs to the in-
Fig 5. Protein synthesis in canine proximal and distal aorta
in organ culture. Treatment of proximal and distal canine
aortic segments with PMA 100 nmol/L (A) and throm-
bin 20 U/mL (B) for 24 hours did not significantly
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creased PDGF production by aortic segments in the
response to PMA appears to be limited. We found
no measurable increase in PDGF secretion in
response to PMA. PMA treatment of human saphe-
nous vein SMCs causes an increase in mRNA for the
PDGF-A chain,22 but protein production has not
been previously reported and gene expression does
not necessarily correspond to protein secretion.23
The amount of PDGF produced by early-passage
aortic SMCs is low,24 considerably less than by
ECs,7 and is near the detectable limits of our
radioreceptor assay, so small increases in PDGF
secretion might not be detected.
The results of the present study parallel those
obtained in the study of monocyte adherence to aortic
segments in organ culture.21 Interleukin-1, lipopolysac-
charide, and thrombin increased monocyte adherence in
both the proximal and the distal aorta in organ culture,
but PMA increased monocyte adherence only in the
proximal aorta. The distal aorta in organ culture was
uniquely unresponsive to PMA. Monocytic cell adhe-
sion to cultured ECs harvested from the proximal and
the distal aorta increased after treatment with all ago-
nists, including PMA. These parallel results suggest the
existence of regional differences that are maintained in
organ culture but obscured in cell culture. Because
organ culture minimizes disruption of normal tissue
architecture,7,12,21,25 it may provide more a faithful 
representation of cellular function in vivo than does cell
culture.
The regional variation in response to PMA may
be due to differences in amount or state of activation
of PKC in the proximal and the distal aorta. Many
reports document differences in EC function and
SMC phenotype in cells cultured from different vas-
cular beds. ECs from different vascular beds express
different PKC isoforms, and expression changes
with EC differentiation.26 For example, cultured rat
cerebral microvascular ECs express PKC-α, -β, -δ, 
-ε, and -η, whereas rat aortic ECs express only PKC-
α and -δ.27 It is possible that different isoforms are
expressed in ECs from various regions of the same
vessel because of embryologic diversity of the ECs or
differences in EC “differentiation” or “activation”
due to hemodynamic forces to which the ECs are
exposed. Inasmuch as both proximal and distal aor-
tic ECs respond to PMA in culture, it is more likely
that the PKC isoforms expressed by the aortic cells
are similar, but the state of activation of the PKC iso-
forms in cells from diverse regions of the aorta may
be different. PKC isoforms α, γ, and ζ are present in
rat SMCs isolated from the normal and hypertro-
phied aorta induced by a coarctation, but in cells
from the hypertrophied aorta the PKC-α is activat-
ed.28 It is possible that in our study PKC was 
chronically activated in the distal aorta but not the
proximal aorta, perhaps on the basis of hemody-
namic factors. This chronic activation could lead to
increased PDGF production and SMC proliferation,
causing increased susceptibility to atherosclerotic
lesions. Further studies are needed to determine the
isoforms of PKC present in the proximal and distal
aorta and the distribution and level of activation of
the PKC. In addition, it remains for future studies to
identify the cause of such changes.
The effect of a different agonist, thrombin, on
PDGF production by canine aortic segments was
also studied in organ culture. Both proximal and dis-
Table II. Cell-secreted protein synthesis in canine aortic endothelial cells after PMA treatment
Protein synthesis by PMA treatment (percent incorporation of [3H]-leucine × 1000)
Aortic segment 0 nmol/L PMA 10 nmol/L PMA 100 nmol/L PMA
Ascending thoracic 240 ± 80 230 ± 60 290 ± 60
Descending thoracic 370 ± 90 280 ± 70 270 ± 70
Abdominal 140 ± 50 190 ± 50 250 ± 70
Infrarenal 180 ± 40 170 ± 50 240 ± 70
Table I. Cell-associated protein synthesis in canine aortic endothelial cells after PMA treatment
Protein synthesis by PMA treatment (percent incorporation of [3H]-leucine × 1000)
Aortic segment 0 nmol/L PMA 10 nmol/L PMA 100 nmol/L PMA
Ascending thoracic 890 ± 380 880 ± 370 840 ± 360
Descending thoracic 970 ± 400 880 ± 370 940 ± 390
Abdominal 600 ± 270 750 ± 330 680 ± 320
Infrarenal 620 ± 270 710 ± 320 670 ± 320
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tal aortic segments were unresponsive to thrombin.
This is in sharp contrast to the effects of thrombin in
our cell culture experiments and in cell culture stud-
ies by other investigators demonstrating increased
PDGF secretion in response to thrombin.8,10,29
Thrombin exerts its effect on PDGF by two differ-
ent mechanisms. Thrombin causes a significant
release of PDGF from EC before de novo protein
synthesis10 by direct proteolytic cleavage of matrix-
associated forms of PDGF.11 In addition, thrombin
increases PDGF gene expression and protein pro-
duction.8,11,29 This is also an important mechanism,
inasmuch as proteolytically inactive thrombin
increases PDGF secretion.8 Thrombin has been
shown to activate PKC, so it may also stimulate
PDGF synthesis through this mechanism. The lack
of effect of thrombin in organ culture may be a
reflection of the inaccessibility of matrix-bound
PDGF to thrombin cleavage, inactivation of throm-
bin by other substances produced by the arterial
wall, or minimal changes at early time points missed
because of lack of sensitivity of the assay. Heparin is
reported to displace PDGF precursors from the cell
membrane or extracellular matrix into the condi-
tioned medium,11 but heparin alone had no effect
on PDGF secretion by our EC cultures. When both
heparin (15 U/mL) and thrombin were added,
however, PDGF secretion increased twofold above
that achieved with thrombin alone (data not
shown). In organ culture, the addition of heparin
with thrombin did not increase PDGF secretion,
suggesting that the PDGF available for proteolytic
release in cell culture is not available in organ 
culture.
Differences in proximal and distal aortic PDGF
secretion in organ culture may be the result of intrin-
sic differences in ECs related to differences in embry-
onic origins of these cells, changes in phenotype
caused by environmental factors in vivo, or, perhaps
more probably, a combination of these. Vasculogenesis
is characterized by a dorsal-to-ventral gradient.30
Consequently, ECs in different locations may have dif-
ferent embryologic histories leading to intrinsic cellu-
lar differences. Differences in PDGF production based
on embryologic origin of the ECs have not been
reported, but other regional variations in EC function
have been noted. Expression of von Willebrand factor
(vWF) by ECs in the abdominal aorta31 but not in the
thoracic aorta32 may be the result of EC development
from distinct vWF-positive and vWF-negative
sources,33 not environmental factors.34 Sustained ele-
vation of basal and stimulated PDGF production by
first-passage distal aortic ECs in comparison with prox-
imal aortic ECs suggests that intrinsic differences in
the ECs exist, because identical cell culture environ-
ments did not result in equivalent PDGF production.
Intrinsic differences, however, cannot explain all of the
findings in the present study, inasmuch as distal aortic
segments were unresponsive to PMA in organ culture
but distal aortic ECs responded to PMA in cell culture.
Environmental factors may alter the phenotype of
vascular wall cells. An example is found in the change
in SMC phenotype after arterial injury. There are
multiple hemodynamic differences between the
proximal aorta and the distal aorta, and the shear
stress fluctuation, flow reversal35,36 and separation of
flow at the bifurcation create regions where chronic
injury and increased residence time for injurious or
stimulatory agents might result in a sustained “acti-
vation” of distal aortic ECs. Alterations in EC func-
tion caused by hemodynamic factors are usually tran-
sient, the function returning to baseline after removal
of the environmental stress and modulating rapidly in
vitro. Thus it is unlikely that environmental factors
explain the regional differences in baseline PDGF
production seen in this study and the regional differ-
ences in monocyte adhesion noted previously,
because these differences were retained in primary
culture, which suggests a relatively “permanent”
change. On the other hand, the unresponsiveness of
the distal aorta to PMA in organ culture was not
maintained by ECs in cell culture, suggesting that
environmental factors may affect response, perhaps
through sustained activation of PKC.
In summary, the distal canine aorta produces
more PDGF than the proximal canine aorta under
unstimulated conditions in organ culture; this find-
ing is also noted in ECs cultured from these loca-
tions. In organ culture, however, the distal aorta is
uniquely unresponsive to stimulation by PMA.
These findings may be the result of intrinsic cellular
differences between the proximal and the distal
aorta or of environmental differences that result in a
chronic “activation” of the distal aorta. Increased
PDGF production in the distal aorta may have a
paracrine effect, stimulating SMC migration and
proliferation and thus contributing to the develop-
ment of infrarenal atherosclerosis.
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